Edwards Lifesciences Corporation (EW): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Edwards Lifesciences Corporation ( EW) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Edwards Lifesciences Corporation rose $2.16 (3.1%) to $72.51 on average volume. Throughout the day, 1,529,638 shares of Edwards Lifesciences Corporation exchanged hands as compared to its average daily volume of 1,462,000 shares. The stock ranged in a price between $69.54-$72.62 after having opened the day at $69.75 as compared to the previous trading day's close of $70.35. Other companies within the Health Care sector that increased today were: Peregrine Pharmaceuticals ( PPHM), up 47.6%, Tekmira Pharmaceuticals Corporation ( TKMR), up 29.7%, Arrowhead Research Corporation ( ARWR), up 24.5% and Tianyin Pharmaceutical ( TPI), up 17.8%.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation has a market cap of $7.4 billion and is part of the health services industry. Shares are up 5.0% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Edwards Lifesciences Corporation a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and feeble growth in the company's earnings per share.

On the negative front, XOMA ( XOMA), down 27.8%, IMRIS ( IMRS), down 22.2%, Synta Pharmaceuticals ( SNTA), down 13.5% and SunLink Health Systems ( SSY), down 11.3% , were all laggards within the health care sector with Mylan ( MYL) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)